Portal:CPTAC/Hallmarks

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Current revision (18:59, 5 October 2017) (view source)
(added Therapeutics category)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
-
{| style="margin: 10px; background-color:#eaf2ee"
+
{| style="width:100%; margin: 10px; background-color:#eaf2ee"
-
|width=100px; cell padding=50px; style="text-align:center;"|'''Sustaining proliferative signaling''' {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmarks/Proliferative}} View all [[Portal:CPTAC/Hallmark/Proliferative|hallmark pathways]]
+
|width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}}
-
|width=100px; style="text-align:center;"|'''Evading growth suppressors'''{{#pwImage:Pathway:WP3972|250px||PDGFR-beta pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}}
-
|width=100px; style="text-align:center;"|'''Activating invasion and metastasis''' {{#pwImage:Pathway:WP2828|250px||Bladder Cancer}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Invasion|<big><u><b>Activating invasion and metastasis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Invasion}}
-
|width=100px; style="text-align:center;"|'''Enabling replicative immortality''' {{#pwImage:Pathway:WP581|250px||EPO Receptor Signaling}}
+
|-
|-
-
|width=100px|{{#pwImage:Pathway:WP673|250px||ErbB Signaling Pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/immortality|<big><u><b>Enabling replicative immortality</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/immortality}}
-
|width=100px|{{#pwImage:Pathway:WP585|250px||Interferon type I signaling pathways}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Angiogenesis|<big><u><b>Inducing angiogenesis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Angiogenesis}}
-
|width=100px|{{#pwimage:Pathway:WP3|250px||Transcriptional activation by NRF2}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Resisting|<big><u><b>Resisting cell death</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Resisting}}
-
|width=100px|{{#pwimage:Pathway:WP4018|250px||Pathways in Renal Cancer}}
+
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Deregulating|<big><u><b>Deregulating cellular energetics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Deregulating}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}}
 +
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Therapeutics|<big><u><b>Therapeutics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Therapeutics}}
|}
|}

Current revision

Sustaining proliferative signaling

Hepatocyte growth factor receptor signaling (Homo sapiens)

Image does not exist
Hepatocyte growth factor receptor signaling
Evading growth suppressors

TGF-beta receptor signaling (Homo sapiens)

Image does not exist
TGF-beta receptor signaling
Activating invasion and metastasis

MFAP5-mediated ovarian cancer cell motility and invasiveness (Homo sapiens)

Image does not exist
MFAP5-mediated ovarian cancer cell motility and invasiveness
Enabling replicative immortality

Wnt signaling (Homo sapiens)

Image does not exist
Wnt signaling
Inducing angiogenesis

VEGFA-VEGFR2 signaling (Homo sapiens)

Image does not exist
VEGFA-VEGFR2 signaling
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

Metabolic reprogramming in colon cancer (Homo sapiens)

Image does not exist
Metabolic reprogramming in colon cancer
Genome instability and mutation

Nucleotide excision repair (Homo sapiens)

Image does not exist
Nucleotide excision repair
Tumor promoting inflammation

IL6 signaling (Homo sapiens)

Image does not exist
IL6 signaling
Avoiding immune destruction

Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens)

Image does not exist
Altered glycosylation of MUC1 in tumor microenvironment
Therapeutics

MicroRNA for targeting cancer growth and vascularization in glioblastoma (Homo sapiens)

Image does not exist
MicroRNA for targeting cancer growth and vascularization in glioblastoma
Personal tools